166.29
price up icon0.03%   0.05
after-market アフターアワーズ: 166.18 -0.11 -0.07%
loading
前日終値:
$166.24
開ける:
$165.5
24時間の取引高:
859.12K
Relative Volume:
0.74
時価総額:
$10.10B
収益:
$4.16B
当期純損益:
$-368.48M
株価収益率:
-27.39
EPS:
-6.0701
ネットキャッシュフロー:
$1.28B
1週間 パフォーマンス:
+1.92%
1か月 パフォーマンス:
+1.59%
6か月 パフォーマンス:
+46.73%
1年 パフォーマンス:
+22.78%
1日の値動き範囲:
Value
$165.08
$168.19
1週間の範囲:
Value
$161.38
$168.19
52週間の値動き範囲:
Value
$95.49
$182.99

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
名前
Jazz Pharmaceuticals Plc
Name
セクター
Healthcare (1112)
Name
電話
353-1-634-7800
Name
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
職員
2,800
Name
Twitter
@jazzpharma
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
JAZZ's Discussions on Twitter

Compare JAZZ vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
JAZZ
Jazz Pharmaceuticals Plc
166.29 10.10B 4.16B -368.48M 1.28B -6.0701
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
465.02 117.03B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
783.65 82.35B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
833.54 51.64B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
308.48 42.58B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
346.42 38.87B 4.98B 69.60M 525.67M 0.5198

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-24 ダウングレード UBS Buy → Neutral
2025-07-15 開始されました Deutsche Bank Buy
2025-03-07 アップグレード UBS Neutral → Buy
2025-02-26 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-02-13 アップグレード Wells Fargo Equal Weight → Overweight
2024-12-12 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-05 開始されました Goldman Buy
2024-01-03 開始されました Robert W. Baird Outperform
2023-11-27 ダウングレード UBS Buy → Neutral
2023-09-29 開始されました Raymond James Mkt Perform
2023-06-12 再開されました Wells Fargo Equal Weight
2022-12-09 アップグレード Goldman Neutral → Buy
2022-06-14 開始されました UBS Buy
2022-04-06 ダウングレード Goldman Buy → Neutral
2021-11-19 再開されました Goldman Buy
2021-10-07 再開されました Jefferies Buy
2021-10-05 開始されました Citigroup Buy
2021-09-23 開始されました Needham Buy
2021-05-19 再開されました JP Morgan Overweight
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-05 繰り返されました H.C. Wainwright Buy
2021-02-03 アップグレード Piper Sandler Neutral → Overweight
2021-01-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-16 開始されました UBS Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-10-09 繰り返されました H.C. Wainwright Buy
2020-09-14 ダウングレード Goldman Neutral → Sell
2020-09-14 再開されました JP Morgan Overweight
2020-08-06 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-28 アップグレード Wolfe Research Peer Perform → Outperform
2020-07-23 アップグレード H.C. Wainwright Neutral → Buy
2020-04-06 開始されました Jefferies Buy
2020-03-12 アップグレード Bernstein Mkt Perform → Outperform
2020-01-08 開始されました Goldman Neutral
2019-08-21 ダウングレード Piper Jaffray Overweight → Neutral
2019-06-11 開始されました Barclays Overweight
2019-03-20 開始されました SunTrust Buy
2018-12-14 開始されました Wolfe Research Peer Perform
2018-11-08 繰り返されました B. Riley FBR Buy
2018-08-08 繰り返されました Stifel Buy
2018-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-03-23 繰り返されました H.C. Wainwright Neutral
2018-03-19 アップグレード Morgan Stanley Equal-Weight → Overweight
すべてを表示

Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース

pulisher
08:36 AM

LSV Asset Management Sells 41,884 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

08:36 AM
pulisher
06:00 AM

Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026 - GlobeNewswire Inc.

06:00 AM
pulisher
Feb 11, 2026

Is the Options Market Predicting a Spike in Jazz Pharmaceuticals Stock? - Yahoo Finance

Feb 11, 2026
pulisher
Feb 10, 2026

Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026 - PR Newswire UK

Feb 10, 2026
pulisher
Feb 10, 2026

Essex Investment Management Co. LLC Invests $2.70 Million in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Feb 10, 2026
pulisher
Feb 08, 2026

Jazz Pharmaceuticals (JAZZ) Valuation After HERIZON GEA Trial Upside And Planned 2026 sBLA Filing - simplywall.st

Feb 08, 2026
pulisher
Feb 08, 2026

Renaissance Group LLC Sells 7,254 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Feb 08, 2026
pulisher
Feb 07, 2026

Lupin Receives Tentative Approval from U.S. FDA for Calcium, Magnesium, Potassium, and Sodium Oxybates Oral SolutionLupin | Press Release - lupin.com

Feb 07, 2026
pulisher
Feb 07, 2026

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 07, 2026
pulisher
Feb 06, 2026

How HERIZON-GEA’s First-Line GEA Data And sBLA Plan At Jazz Pharmaceuticals (JAZZ) Has Changed Its Investment Story - simplywall.st

Feb 06, 2026
pulisher
Feb 05, 2026

The Best Biotech Stocks to Buy - Morningstar

Feb 05, 2026
pulisher
Feb 05, 2026

Allianz Asset Management GmbH Purchases 30,537 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Feb 05, 2026
pulisher
Feb 04, 2026

Zacks Research Brokers Lower Earnings Estimates for JAZZ - MarketBeat

Feb 04, 2026
pulisher
Feb 03, 2026

New Drugs Take Center Stage as Biogen Heads Into Q4 Earnings - Yahoo Finance

Feb 03, 2026
pulisher
Feb 03, 2026

What is Zacks Research's Estimate for JAZZ Q1 Earnings? - MarketBeat

Feb 03, 2026
pulisher
Feb 03, 2026

Truist Securities Raises Jazz Pharmaceuticals (JAZZ) Price Target After HERIZON-GEA Trial - Insider Monkey

Feb 03, 2026
pulisher
Feb 03, 2026

Strs Ohio Sells 14,393 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Feb 03, 2026
pulisher
Feb 02, 2026

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a 32% Potential Upside and Strong Buy Ratings - DirectorsTalk Interviews

Feb 02, 2026
pulisher
Feb 02, 2026

What is the target price for Jazz Pharmaceuticals plc stockMarket Risk Analysis & High Win Rate Trade Tips - baoquankhu1.vn

Feb 02, 2026
pulisher
Feb 02, 2026

Autistic Disorder Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Jazz Pharma, Axial Therapeutics, Eli Lilly and Company, Scioto Bioscienc - Barchart.com

Feb 02, 2026
pulisher
Feb 02, 2026

Autistic Disorder Pipeline 2025: Therapies Under - openPR.com

Feb 02, 2026
pulisher
Feb 01, 2026

Top Investors’ Stock Portfolio: 10 Mid-cap Stocks To Buy - Insider Monkey

Feb 01, 2026
pulisher
Jan 31, 2026

The Truth About Jazz Pharmaceuticals: Why Wall Street Suddenly Can’t Shut Up - AD HOC NEWS

Jan 31, 2026
pulisher
Jan 31, 2026

Is Jazz Pharmaceuticals (JAZZ) Offering An Opportunity After Recent Share Price Pullback - Yahoo Finance

Jan 31, 2026
pulisher
Jan 31, 2026

Is Jazz Pharmaceuticals (JAZZ) Offering Opportunity After A 32% One Year Share Price Gain - simplywall.st

Jan 31, 2026
pulisher
Jan 30, 2026

These 4 Measures Indicate That Jazz Pharmaceuticals (NASDAQ:JAZZ) Is Using Debt Reasonably Well - 富途牛牛

Jan 30, 2026
pulisher
Jan 30, 2026

Jazz Pharmaceuticals PLC $JAZZ Shares Bought by Great Lakes Advisors LLC - MarketBeat

Jan 30, 2026
pulisher
Jan 29, 2026

Lewy Body Dementia Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Jazz Pharma, Allergan, Noven Pharma, Takeda Pharma, Eli Lilly, Mallinckrodt - Barchart.com

Jan 29, 2026
pulisher
Jan 29, 2026

Mitsubishi UFJ Trust & Banking Corp Raises Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jan 29, 2026
pulisher
Jan 28, 2026

Aug Weekly: Is ADPT a good ESG investmentStop Loss & Stock Portfolio Risk Management - baoquankhu1.vn

Jan 28, 2026
pulisher
Jan 27, 2026

Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed? - Finviz

Jan 27, 2026
pulisher
Jan 26, 2026

Auvelity Continues to Aid AXSM's Top Line: More Upside in 2026? - Yahoo Finance

Jan 26, 2026
pulisher
Jan 26, 2026

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Unpacking A Promising 28% Upside Potential - DirectorsTalk Interviews

Jan 26, 2026
pulisher
Jan 26, 2026

How Boehringer Ingelheim Oncology Collaboration Could Shape Jazz Pharmaceuticals' (JAZZ) Dual HER2 Strategy - simplywall.st

Jan 26, 2026
pulisher
Jan 26, 2026

Universal Beteiligungs und Servicegesellschaft mbH Cuts Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jan 26, 2026
pulisher
Jan 23, 2026

Assessing Jazz Pharmaceuticals (JAZZ) Valuation After New Boehringer Ingelheim Oncology Collaboration - simplywall.st

Jan 23, 2026
pulisher
Jan 23, 2026

Aug Update: Should I invest in Kaltura Inc before earningsEarnings Miss & Intraday High Probability Alerts - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 23, 2026

Dip Buying: Why is Jazz Pharmaceuticals plc stock going upEarnings Risk Report & Stepwise Trade Signal Implementation - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 21, 2026

Acute Myeloid Leukemia Market Forecast to 2034: 7MM Opportunity, Strong CAGR, 43,500 Annual Cases, and Pipeline-Driven Growth | DelveInsight - Barchart.com

Jan 21, 2026
pulisher
Jan 19, 2026

Lmcg Investments LLC Trims Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jan 19, 2026
pulisher
Jan 19, 2026

Aug Mood: Will Jazz Pharmaceuticals plc benefit from green energy policiesTrade Exit Report & Community Consensus Stock Picks - baoquankhu1.vn

Jan 19, 2026
pulisher
Jan 18, 2026

Jazz Pharmaceuticals (JAZZ) Is Up 5.1% After Monetizing FDA Voucher And Expanding Oncology Collaboration - Yahoo Finance

Jan 18, 2026
pulisher
Jan 17, 2026

Is Jazz (JAZZ) Quietly Recasting Its Oncology Strategy Through HER2 Partnerships And Voucher Monetization? - simplywall.st

Jan 17, 2026
pulisher
Jan 17, 2026

New York State Teachers Retirement System Sells 9,223 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Jan 17, 2026
pulisher
Jan 16, 2026

JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug - MSN

Jan 16, 2026
pulisher
Jan 16, 2026

Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Recent Share Price Momentum - simplywall.st

Jan 16, 2026
pulisher
Jan 15, 2026

JPM26: Jazz sells PRV for $200m, targets deals in 2026 - Pharmaceutical Technology

Jan 15, 2026
pulisher
Jan 15, 2026

JAZZJazz Pharmaceuticals Plc Latest Stock News & Market Updates - Stock Titan

Jan 15, 2026
pulisher
Jan 15, 2026

Jazz Sells Priority Review Voucher for $200M as Program’s Renewal Languishes in Senate - BioSpace

Jan 15, 2026
pulisher
Jan 14, 2026

Jazz Pharmaceuticals stock rating reiterated at Outperform by RBC Capital - Investing.com Nigeria

Jan 14, 2026
pulisher
Jan 14, 2026

Jazz Pharmaceuticals Soars with Promising HERIZON-GEA-01 Results - timothysykes.com

Jan 14, 2026

Jazz Pharmaceuticals Plc (JAZZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
大文字化:     |  ボリューム (24 時間):